You are here: All Products  > Antengene Approved to Launch XPO1 Inhibitor for Multiple Myeloma

Antengene Approved to Launch XPO1 Inhibitor for Multiple Myeloma

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products